Navigation Links
Repligen Reports First Quarter Fiscal Year 2010 Financial Results
Date:8/6/2009

Protein A, the sales of which partially fund the advancement of our development pipeline while supporting our financial stability. Repligen's corporate headquarters are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453. Additional information may be requested from www.repligen.com.

                             REPLIGEN CORPORATION
                           STATEMENTS OF OPERATIONS
                                 (Unaudited)

                                             Three months ended June 30,
                                             ---------------------------
                                                 2009            2008
                                                 ----            ----
    Revenue:
      Product revenue                         $2,472,590      $5,693,343
      Royalty and other revenue                2,588,263       7,966,902
                                               ---------       ---------
        Total revenue                          5,060,853      13,660,245

    Operating expenses:
      Cost of product revenue                  1,270,474       1,846,401
      Cost of royalty and other revenue          317,745         325,000
      Research and development                 3,383,000       2,084,125
      Selling, general and administrative      1,517,357       1,446,571
        Total operating expenses               6,488,576       5,702,097
                                               ---------       ---------

    Income (loss) from operations             (1,427,723)      7,958,148
    Investment income                            322,419         532,585
    Interest expense                                (676)         (1,905)
                                                    ----          ------
    Income (loss) before income taxes         (1,105,980)      8,488,828
    Income tax (b
'/>"/>
SOURCE Repligen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Repligen Announces Conference Call of Third Quarter Fiscal Year 2008 Results
2. Repligen Announces Settlement with Bristol-Myers Squibb in Orencia(R) Lawsuit
3. Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results
4. Repligen Announces Conference Call of First Quarter Fiscal Year 2009 Results
5. Repligen Receives Research Grants to Support Friedreichs Ataxia Development Program
6. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
7. Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT
8. Repligen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference Monday, November 10th, 4:55 p.m. EST
9. Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results
10. Repligen to Present at the BIO CEO & Investor Conference Monday, February 9th, 11:30 a.m. EST
11. Repligen Reports Third Quarter Fiscal Year 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... According to a new market research report ... and Joint) Market (By Technology - Stem Cell ... Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic ... Share, Growth, Trends and Forecast, 2013 - 2019" ... was valued at USD 2.6 billion in 2012 ...
(Date:7/28/2014)... 28, 2014 Proove Biosciences , ... be exhibiting data and research conducted through their latest ... Intervention Society’s (ISIS) 22nd Annual Scientific Meeting. The ... Hyatt Regency, in Orlando, Florida. , The ... competence of physicians who care for patients suffering specificity ...
(Date:7/28/2014)... Research and Markets has announced the addition ... report to their offering. ... the designing and engineering of completely new biological parts, ... natural biological systems that provide improved and desirable functions. ... genetic engineering because it not only alters existing metabolic ...
(Date:7/28/2014)... -   JOLT , a leading technology accelerator, announced ... growing portfolio of startups. Next-level tech and boundary-pushing innovation ... JOLT accelerator, and Cohort four is no exception, with ... Since its launch in July 2012, JOLT has produced ... Now at 23 investments, JOLT,s portfolio has an overall ...
Breaking Biology Technology:Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting 2Global Synthetic Biology Market 2014-2018 2JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort 2JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort 3
... RYE, N.Y., Nov. 10 Curemark, LLC, a drug ... autism, was one of 32 biotech companies headed by ... 2009 forum, held recently in Silicon Valley, Madison, Wisconsin, ... from the U.S. and abroad applied to participate. , ...
... ... the prestigious eHealthcare Leadership Award given annually to organizations representing the best web sites ... ... provider of clinical trials information, received its fifth consecutive eHealthcare Leadership Award and seventh ...
... N.J., Nov. 10 Regado Biosciences, a privately held company leading ... Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will ... in Philadelphia, Pennsylvania. Ms. McDonald,s presentation ... Monday, November 16 and will ...
Cached Biology Technology:Curemark Presents at Springboard Enterprises Life Sciences Forum 2CenterWatch Honored a Fifth Consecutive Year for Best Healthcare Content 2Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16, 2009 2
(Date:7/28/2014)... (July 28, 2014) Rice University researchers are ... of varying flexibility that can be used as microscale ... proof that "bead-spring" polymers, introduced as theory in the ... as required and should be of interest to materials ... The work led by Rice chemical and biomolecular engineer ...
(Date:7/28/2014)... and treat HIV infection has been problematic until now ... arouse as they get rid of the invaders. Now, ... and the National Institutes of Health (NIH) have demonstrated ... around the time of infection could have long-term ... appeared in Nature . , Interferons, named ...
(Date:7/28/2014)... Amundsen became the first man to reach the South ... later, an international team of scientists led by Joe ... that air pollution from industrial activities arrived long before. ... widely spaced locations around the Antarctic continent, including the ... precise reconstruction to date of lead pollution over the ...
Breaking Biology News(10 mins):Seeing is bead-lieving 2Interfering with interferon 2Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 2Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 3
... most important fruit trees in the world. Citrus has a ... 4,000 years. Until now, however, the exact genetic origins of ... lemon ( C. limon ), and grapefruit ( C. paradisi ... China has published a study in the Journal of the ...
... at Dana-Farber Cancer Institute have received a $5.6 million ... and the Army Research Office (ARO) to develop transient ... pathogens. The ultimate goal is to develop a ... of receiving it in a laboratory. Wayne A. ...
... , CHAPEL HILL, N.C. Researchers at the University of ... can make brain cells resistant to programmed cell death or ... microRNA-29 or miR-29, has already been shown to be in ... and Huntington,s disease. Thus, the discovery could herald a new ...
Cached Biology News:Genetic origin of cultivated citrus determined 2Dana-Farber receive $5.6 million grant to develop rapid countermeasures to infectious agents 2New molecule could save brain cells from neurodegeneration, stroke 2New molecule could save brain cells from neurodegeneration, stroke 3
Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, glycerol solution....
"BioTracker 6X Bromophenol Blue Tracking Dye is composed of 60% St DI H2O, 30% Glycerol, 10% 10XTE, 0.25% BPB Dye and 0.85% SDS....
Request Info...
Agarose, low melting/gelling temperature, high MW separation (>1000 bp), 25 g. Suitable for enzymatic modifications. Nuclease-free.Gel point: 24-30 C, EEO (-mr): 300 gm/cm2. Category: Nucleotides &...
Biology Products: